KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bio-Rad Laboratories (BIO) Enterprise Value (2016 - 2025)

Bio-Rad Laboratories (BIO) has disclosed Enterprise Value for 17 consecutive years, with -$1.5 billion as the latest value for Q4 2025.

  • On a quarterly basis, Enterprise Value rose 7.44% to -$1.5 billion in Q4 2025 year-over-year; TTM through Dec 2025 was -$1.5 billion, a 7.44% increase, with the full-year FY2025 number at -$1.5 billion, up 7.44% from a year prior.
  • Enterprise Value was -$1.5 billion for Q4 2025 at Bio-Rad Laboratories, down from -$1.4 billion in the prior quarter.
  • In the past five years, Enterprise Value ranged from a high of -$395.6 million in Q2 2023 to a low of -$1.9 billion in Q1 2023.
  • A 5-year average of -$942.6 million and a median of -$770.4 million in 2021 define the central range for Enterprise Value.
  • Peak YoY movement for Enterprise Value: skyrocketed 77.14% in 2023, then plummeted 306.57% in 2024.
  • Bio-Rad Laboratories' Enterprise Value stood at -$476.3 million in 2021, then crashed by 275.92% to -$1.8 billion in 2022, then skyrocketed by 77.14% to -$409.4 million in 2023, then tumbled by 306.57% to -$1.7 billion in 2024, then rose by 7.44% to -$1.5 billion in 2025.
  • Per Business Quant, the three most recent readings for BIO's Enterprise Value are -$1.5 billion (Q4 2025), -$1.4 billion (Q3 2025), and -$1.4 billion (Q2 2025).